Bio Rad

Hercules, United States Founded: 1952 • Age: 74 yrs
Portfolio of products and services for life science research and clinical diagnostic markets
Annual revenue $2.6B Latest available
Total funding - 14 rounds
Employees 7700 Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors 8 Brand Intelligence

About Bio Rad

Bio Rad is a company based in Hercules (United States) founded in 1952. The company has 7,700 employees as of December 31, 2024. Bio Rad has completed 8 acquisitions, including Abd Serotec, Celsee Diagnostics and Dropworks. Bio Rad operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.

  • Headquarter Hercules, United States
  • Employees 7700 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Bio-Rad Laboratories, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $2.57 B (USD)
    -3.92
    as on Dec 31, 2024
  • Net Profit
    -$1.84 B (USD)
    -189.37
    as on Dec 31, 2024
  • EBITDA
    $503.8 M (USD)
    -12.56
    as on Dec 31, 2024
  • Latest Funding Round
    $66.88 K (USD), Grant

    Dec 21, 2021

  • Investors
    HHS

    & 2 more

  • Employee Count
    7700

    as on Dec 31, 2024

  • Investments & Acquisitions
    Abd Serotec

    & 7 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Bio Rad

Bio Rad is a publicly listed company on the NYSE with ticker symbol BIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NYSE · Ticker: BIO · Sector: Health technology · USA

People of Bio Rad

Headcount 5000-10000
Employee Profiles 516
Board Members and Advisors 5
Employee Profiles
People
Delphine Mower
HR Generalist
People
Christophe Pigani
Directeur Régional Des Ventes
People
Stephen Beyer
V.p. Global Rewards, Benefits & HR Technology
People
Norman Schwartz
Chairman, President & CEO

Unlock access to complete

Board Members and Advisors
people
Arnold A. Pinkston
Director

Unlock access to complete

Funding Insights of Bio Rad

Investors in Bio Rad

Bio Rad has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Military Health.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for Bio Rad

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bio Rad

Bio Rad has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Abd Serotec, Celsee Diagnostics and Dropworks.

Investments
Premium access

Investment portfolio details for Bio Rad

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
PCR diagnostic kits are manufactured by PCR|ONE for medical use.
Locked Locked 2019 Locked
Digital PCR instruments are manufactured for laboratory use.
Locked Locked 2016 Locked
Digital PCR solutions for research are developed and analyzed.
Locked Locked 2013 Locked
Premium access

Complete acquisition details for Bio Rad

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Bio Rad

Premium access

Detailed financials for Bio Rad

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Bio Rad Comparisons

Bio Rad Primary company
Description
Portfolio of products and services for life science research...
Location
Hercules, United States
Founded Year
1952
Annual Revenue
$2.57 B (USD)
Net Profit
-$1.84 B (USD)
EBITDA
$503.8 M (USD)
Employees
7,700
As of 2024
Premium access

Peer comparison for Bio Rad

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Bio Rad

Bio Rad operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Assay kits for ultra-sensitive biomarker detection are developed.
Locked Locked Locked
Primary antibodies and instruments for immunohistochemistry are manufactured.
Locked Locked Locked
Merck is engaged in science and technology solutions globally.
Locked Locked Locked
Tissue hypothermic storage and cryopreservation freeze media are developed.
Locked Locked Locked
Online platform offering life sciences reagents and kits
Premium access

Detailed competitors of Bio Rad

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Bio Rad

Premium access

Complete news archive for Bio Rad

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bio Rad

Bio Rad was founded in 1952 and raised its 1st funding round 51 years after it was founded.

Bio Rad is headquartered in Hercules, United States. It is registered at Hercules, California, United States.

As of Dec 31, 2024, the latest employee count at Bio Rad is 7,700.

Annual revenue of Bio Rad is $2.57B as on Dec 31, 2024.

Bio-Rad was founded in 1952 and is headquartered in Hercules, United States. Operations focus on the biotechnology and healthcare sectors, where a variety of productsincluding reagents, instruments, software, and apparatusare developed for laboratory applications. These support drug discovery, functional genomics, proteomics, food pathogen testing, and studies of biological processes. Services extend to clinical diagnostics, with emphasis on research tools used globally in scientific and medical settings.

Bio Rad's top competitors include Biocare Medical, Merck and Siemens Healthineers.

Yes, Bio Rad is publicly traded on NYSE under the ticker symbol BIO.

Bio Rad has made 8 acquisitions, including Abd Serotec, Celsee Diagnostics, and Dropworks.

Bio Rad has 3 investors. Key investors include HHS, European Union, and Military Health.

The ticker symbol of Bio Rad is BIO on NYSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available